Blog

Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management

Photos of Ahmad Tarhini and Patrick Hwu

Jun 6, 2024, 06:30

Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management

Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute, shared on LinkedIn: .

“Chatting with Dr. Patrick Hwu about the latest advances in melanoma management including neoadjuvant immunotherapy as a new standard of care, triplet immuno-oncology combinations, and our efforts in biomarker development to better select the right treatment for our patients.”

Proceed to the video.
Source: Ahmad Tarhini/LinkedIn

Ahmad Tarhini ASCO ASCO24 biomarker development cancer immuno-oncology combinations Melanoma melanoma management Moffitt Cancer Center neoadjuvant immunotherapy OncoDaily Oncology Patrick Hwu Precision Medicine

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage